Clavis Pharma ASA : Clavis Pharma ASA : Appointments of Interim Chairman and Acting CEO

 Clavis Pharma ASA : Clavis Pharma ASA : Appointments of Interim Chairman and
                                  Acting CEO

Oslo, Norway, 22 May 2013

Clavis Pharma ASA (OSE: CLAVIS), announces that the Board of Directors of
Clavis Pharma has appointed Martin Nes, a board member of the Company, as
Interim Chairman of the Board of Directors. Mr Nes replaces Anders P. Wiklund,
who resigned from the Board of Directors effective 21 May 2013.

The Board has also appointed Gunnar Manum, the CFO of Clavis Pharma, to the
additional position of Acting CEO, until a long-term strategic solution is
found for the Company.




Contacts:

Gunnar Manum
Chief Financial Officer
+47 24 11 09 71
+47 95 17 91 90 (mob)
gunnar.manum@clavispharma.com


This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Clavis Pharma ASA via Thomson Reuters ONE
HUG#1703789